If MGMT methylation is circadian in the heterogeneous cells of GBM, it becomes a therapeutic target to deliver TMZ at times when it is unmethylated and, perhaps, to lock the cells at a circadian phase when methylation is physiologically low. Here, MGMT is linked to glioblastoma.